Panel & Live Audience Discussion: Reviewing & Establishing the Translational Challenges of Accelerating Neovascularization Drugs into the Clinic & Beyond
Time: 1:30 pm
day: Conference Day 2
Details:
- Capabilities and limitations of current pre-clinical models in allowing translatable research in nAMD / DME and DR
- Finding optimal clinical biomarkers and endpoints for different development stages in Wet AMD / DME/ DR
- Reviewing the need for updated regulatory guidelines for the measurements of efficacy and safety endpoints such as visual acuity, for the new patient population with choroidal neovascularization